NCT06214416

Brief Summary

NAMETI-Alcohol, from the acronym for Navarra Medical Trialist Initiative, is a pilot study in which two patterns of alcohol consumption, abstention and Mediterranean alcohol-drinking pattern, and their effects on health in the short and medium term will be compared.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2021

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 25, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 19, 2024

Completed
Last Updated

January 19, 2024

Status Verified

January 1, 2024

Enrollment Period

2.2 years

First QC Date

May 25, 2022

Last Update Submit

January 9, 2024

Conditions

Outcome Measures

Primary Outcomes (9)

  • Glucose (mg/dl)

    Changes differences in glucose levels

    1 year

  • HDL-Cholesterol (mg/dl)

    Changes differences in HDL-Cholesterol levels

    1year

  • Total cholesterol (mg/dl)

    Changes differences in total cholesterol levels

    1year

  • Triglycerides (mg/dl)

    Changes differences in triglycerides

    1 year

  • Alanine Aminotransferase (ALT) (IU/L)

    Changes differences in ALT

    1 year

  • Aspartate transaminase (AST) (IU/L)

    Changes differences in AST

    1 year

  • Gamma-glutamyltransferase (GGT) (IU/L)

    Changes differences in GGT

    1 year

  • c-Reactive Protein (CRP) (mg/L)

    Changes differences in CRP

    1 year

  • Blood pressure (mm Hg)

    Changes differences in systolic and diastolic blood pressure

    1 year

Secondary Outcomes (4)

  • Mental health

    1 year

  • Weight (kg)

    1 year

  • Adherence to the intervention

    1 year

  • Body Mass Index (BMI) (kg/m2)

    1 year

Study Arms (4)

Abstention

ACTIVE COMPARATOR

These participants will be encouraged to totally avoid alcohol consumption.

Behavioral: Abstention

Mediterranean alcohol-drinking pattern

ACTIVE COMPARATOR

These participants will be encouraged to change their pattern of consumption to a more Mediterranean way, which includes 5 aspects: moderate alcohol consumption (maximum of 2 drinks/day for women and 4 drinks/day for men), spread consumption throughout the week, drink with meals and never with an empty stomach, prefer wine and mainly red wine, as well as completely avoid episodes of binge-drinking.

Behavioral: Mediterranean alcohol-drinking pattern

Control of abstainers

NO INTERVENTION

This group will include all participants who consume less than 3 alcohol drinks a week at the time of recruitment.

Control of drinkers

NO INTERVENTION

This group will include all participants who don't want to change their alcohol-drinking pattern.

Interventions

AbstentionBEHAVIORAL

All the intervention will be carried out online once a month for a year, focusing on nutritional, behavioral and scientific evidence aspects, that promote abstention.

Abstention

All the intervention will be carried out online once a month for a year, focusing on nutritional, behavioral and scientific evidence aspects, that promote the Mediterranean alcohol-drinking pattern.

Mediterranean alcohol-drinking pattern

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consuming more than 3 drinks a week (except for the abstention-control arm)

You may not qualify if:

  • Sever chronic disease (cancer, cardiovascular disease, chronic hepatitis and mental illness)
  • Pregnant women or breastfeeding
  • Family or personal history of addiction, alcoholism or alcohol abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Navarra

Pamplona, Navarre, 31008, Spain

Location

MeSH Terms

Conditions

Alcohol Drinking

Interventions

Ethanol

Condition Hierarchy (Ancestors)

Drinking BehaviorBehavior

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: It is intended to recruit a total of 100 participants, including two observational cohorts of abstainers and drinkers. The intervention will be carried out in drinkers willing to change their alcohol consumption, divided into 2 groups of 150 participants, the abstention group and the Mediterranean alcohol-drinking pattern group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 25, 2022

First Posted

January 19, 2024

Study Start

November 1, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

January 19, 2024

Record last verified: 2024-01

Locations